Medtronic (MDT) FCF Payout Ratio Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.91% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -3.43% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -18.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -9.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -18.36% |
| Oct 24, 2025 | 9.68% |
| Jul 25, 2025 | 4.27% |
| Apr 25, 2025 | -4.98% |
| Jan 24, 2025 | -1.39% |
| Oct 25, 2024 | 42.01% |
| Jul 26, 2024 | 27.69% |
| Apr 26, 2024 | -12.05% |
| Jan 26, 2024 | 3.22% |
| Oct 27, 2023 | 110.28% |
| Jul 28, 2023 | 28.60% |
| Apr 28, 2023 | -12.55% |
| Jan 27, 2023 | 28.63% |
| Oct 28, 2022 | 48.98% |
| Jul 29, 2022 | 31.91% |
| Apr 29, 2022 | 9.69% |
| Jan 28, 2022 | 5.25% |
| Oct 29, 2021 | -7.06% |
| Jul 30, 2021 | 24.49% |
| Apr 30, 2021 | -11.95% |
| Jan 29, 2021 | 3.25% |
| Oct 30, 2020 | -19.35% |
| Jul 31, 2020 | -130.23% |
| Apr 24, 2020 | 16.44% |
| Jan 24, 2020 | 0.65% |
| Oct 25, 2019 | -2.50% |
| Jul 26, 2019 | 6.84% |
| Apr 26, 2019 | -11.13% |
| Jan 25, 2019 | 3.64% |
| Oct 26, 2018 | 11.50% |
| Jul 27, 2018 | -19.18% |
| Apr 27, 2018 | 47.15% |
| Jan 26, 2018 | 25.38% |
| Oct 27, 2017 | 36.87% |
| Jul 28, 2017 | -3.44% |